Search
Close this search box.
Search

Ava raises $9.7M tu further develop their fertility-tracking wearable

Ava, a company based in Zurich and San Fransisco, raised $9.7 million in Series A funding led by VC Polytech Ventures. Additional funding came from new investors Blue Ocean Ventures and Global Sources as well as existing investors Swisscom and ZKB. This brings the company’s total funding to $12.3 million.

The company, known for the development of a fertility-tracking wearable  officially launched in July. It will use the funding to further product development and ramp up its supply chain, as the Class One device is currently on backorder.

Lea von Bidder, cofounder of Ava serving as president of science and vice president of marketing at the company: “We’ve been pretty much sold out since we started launching, and now we’re at a point where we want to expand the collection, add new features and have more output to keep up so we can move into the European market.”

The Ava bracelet uses sensors to detect the fertility of a woman. It records nine physiological factors that correspond with the rise in hormones indicating the onset of ovulation. According to von Bidder, a couple of thousand women in the US are currently using the device. “We’ve had very good response, and now we are starting to hear about the first pregnancies since using the tracker,” von Bidder said.
A clinical study at the University Hospital of Zurich, which was published shortly after the launch, showed the device accurately detected an averaged of 5.3 fertile days per cycle with 89 percent accuracy. They continued with a second study at the same hospital with a larger sample size (around 200), which will all go towards helping the company advance the capabilities of its device.

“When we set out to do this, we wanted to have a device for women to understand what is going on with their bodies at different stages of life – from wanting to avoid pregnancy, getting pregnant, spacing time between babies, maybe menopause,” von Bidder said. “Fertility made a lot of sense to start, but we were surprised that a lot of the feedback we got was from women trying not to get pregnant.”

While they are far away from the day where women could use the Ava tracker exclusively as a form of birth control, von Bidder said the company’s ultimate goal is to someday provide just that. The company is looking to hire more data scientists and also work with ob-gyns.

“It is my very strong personal mission to some day do this, this holy grail of making a device and app that can work as contraception,” said von Bidder. “That’s going to be a much bigger challenge that will require many more studies and specific targeting at a particular audience.”

“We see a lot more understanding and conversation out there around women’s health and reproductive health choices, and on one hand, that’s really good,” von Bidder said. “On the other, you are still stuck with the options you have. We want to create a solution that we would all personally want to use.”

Whixx

ICT&health World Conference 2024

Experience the future of healthcare at the ICT&health World Conference from May 14th to 16th, 2024!
Secure your ticket now and immerse yourself in groundbreaking technologies and innovative solutions.
Engage with fellow experts and explore the power of global collaborations.

Share this article!

Read also
Balancing regulatory compliance with seamless adoption, healthcare navigates the integration of AI solutions.
A guide to implementing AI in healthcare amid the EU AI Act
AmyWebb-Stephen-Olker
Futurist Amy Webb claims that wearables will evolve into "connectables"
Digital health solutions empower patients to better manage their health and integrate care into their daily lives.
How to improve Digital Patient Engagement to streamline workflows
For people with diabetes, inaccurate blood glucose measurements can lead to errors in diabetes management, including taking the wrong dose of insulin, sulfonylureas, or other medications that can rapidly lower blood glucose.
Smartwatches measuring glucose level: Harmful but easy to buy fake innovations
How to introduce innovation and AI in healthcare organizations if there is no business model for prevention and quality – Our interview with Professor Ran Balicer, the Chief Innovation Officer at Clalit Health Services and founding Director of Clalit Research Institute.
I see no legitimate rationale for delaying the digital transformation in healthcare
Pioneering Cardiac Arrest Detection for Enhanced Survival.
CardioWatch Revolutionizes Cardiac Arrest Detection
Dr. Oscar Díaz-Cambronero, Head of Perioperative Medicine Department at La Fe Hospital, spearheads innovative telemonitoring initiatives revolutionizing patient care
Smartwatches Saving Lives Inside and Outside the Hospital
EIT 2024
EIT Awards 2024. Two European startups are revolutionizing the treatment of cardiovascular diseases
Bertrand Piccard, Swiss explorer and founder of the Solar Impulse Foundation
EIT Summit 2024. What are the trigger points that drive or inhibit innovation?
MMC pioneers wireless monitoring for premature infants with the innovative Bambi Belt, revolutionizing care with improved comfort and mobility.
Wireless Monitoring of Vital Signs in Premature Infants at Máxima MC
Follow us